“Effectiveness and Safety of First-Generation Protease Inhibitors in Real-World Patients With Hepatitis C Virus Genotype 1 Infection in Brazil: A Multicenter Study”. 2017. Clinics 72 (6): 378-85. https://doi.org/10.6061/clinics/2017(06)08.